The anti‑hepatitis B virus activity of sea buckthorn is attributed to quercetin, kaempferol and isorhamnetin

  • Authors:
    • Mohammad K. Parvez
    • Mohammed S. Al‑dosari
    • Omar A. Basudan
    • Rashed N. Herqash
  • View Affiliations

  • Published online on: September 16, 2022     https://doi.org/10.3892/br.2022.1573
  • Article Number: 89
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study assessed the in vitro anti‑­hepatitis B virus (HBV) effects of cold‑adapted sea buckthorn (Hippophae rhamnoides). Sea buckthorn leaf ethanol extracts subjected to chloroform (SB‑Chl), ethyl acetate (SB‑Eac), n‑butanol (SB‑But) and aqueous (SB‑Aqu) fractionation were first examined (MTT assay) for their toxic effects on HepG2 cells. While SB‑Chl (IC50, 32.58 µg/ml) exhibited high cytotoxicity, SB‑Eac, SB‑But SB‑Aqu were non‑toxic at up to 150 µg/ml. High performance liquid chromatography analysis led to the identification of the anti‑HBV active flavonols, quercetin (93.09 µg/g), kaempferol (44.19 µg/g) and isorhamnetin (138.75 µg/g) in the extract. The analysis of the anti‑HBV effects of SB‑Eac, SB‑But and SB‑Aqu (50 µg/ml, each) on HepG2.2.15 cells revealed the marked inhibition of HBsAg and HBeAg expression levels. At the concentration of 10 µg/ml, quercetin and kaempferol exerted potent inhibitory effects on HBsAg (60.5 and 62.3%, respectively) and HBeAg synthesis (64.4 and 60.2%, respectively), as compared to isorhamnetin (30.5 and 28.4%, respectively). The HBV‑polymerase inhibitor drug, lamivudine (2 µM), inhibited HBsAg and HBeAg expression by 87.4 and 83.5%, respectively. The data were in good agreement with a previous in vitro and in silico molecular docking analysis performed by the authors where quercetin, kaempferol and lamivudine had formed stable complexes with HBV‑polymerase binding‑pocket amino acids. On the whole, to the best of our knowledge, the present study provides the first report of the anti‑HBV therapeutic potential of sea buckthorn, attributed to quercetin, kaempferol and isorhamnetin.
View Figures
View References

Related Articles

Journal Cover

November-2022
Volume 17 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Parvez MK, Al‑dosari MS, Basudan OA and Herqash RN: The anti‑hepatitis B virus activity of sea buckthorn is attributed to quercetin, kaempferol and isorhamnetin. Biomed Rep 17: 89, 2022
APA
Parvez, M.K., Al‑dosari, M.S., Basudan, O.A., & Herqash, R.N. (2022). The anti‑hepatitis B virus activity of sea buckthorn is attributed to quercetin, kaempferol and isorhamnetin. Biomedical Reports, 17, 89. https://doi.org/10.3892/br.2022.1573
MLA
Parvez, M. K., Al‑dosari, M. S., Basudan, O. A., Herqash, R. N."The anti‑hepatitis B virus activity of sea buckthorn is attributed to quercetin, kaempferol and isorhamnetin". Biomedical Reports 17.5 (2022): 89.
Chicago
Parvez, M. K., Al‑dosari, M. S., Basudan, O. A., Herqash, R. N."The anti‑hepatitis B virus activity of sea buckthorn is attributed to quercetin, kaempferol and isorhamnetin". Biomedical Reports 17, no. 5 (2022): 89. https://doi.org/10.3892/br.2022.1573